SCHEMBL505106

SCHEMBL505106

CCCCCCC(O)CCCCCCCCCCC(=O)OCCO

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGKA P23743 2/20 0.62
LMNA P02545 2/20 0.59
KDM4E B2RXH2 1/20 0.59
DUSP3 P51452 1/20 0.59
MEN1 O00255 1/20 0.59
KMT2A Q03164 1/20 0.59
FFAR4 Q5NUL3 1/20 0.57
FFAR1 O14842 1/20 0.57
MAPT P10636 1/20 0.54
MGLL Q99685 1/20 0.54
DNM1 Q05193 1/20 0.53
ALDH1A1 P00352 2/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
GPR84 Q9NQS5 1/20 0.50
LPAR6 P43657 1/20 0.49
LPAR1 Q92633 1/20 0.49
LPAR4 Q99677 1/20 0.49
LPAR5 Q9H1C0 1/20 0.49
LPAR2 Q9HBW0 1/20 0.49
LPAR3 Q9UBY5 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16800412 1.00 DGKA (0.62) DGKALMNAKDM4EDUSP3MEN1
SCHEMBL6052723 1.00 DGKA (0.62) DGKALMNAKDM4EDUSP3MEN1
SCHEMBL6052685 1.00 DGKA (0.62) DGKALMNAKDM4EDUSP3MEN1
SCHEMBL28292733 0.98 DGKA (0.61) DGKALMNAKDM4EDUSP3MEN1
SCHEMBL16830136 0.97 DGKA (0.58) DGKALMNAKDM4EDUSP3MEN1
SCHEMBL7561059 0.94 DGKA (0.53) DGKALMNAKDM4EDUSP3MEN1
SCHEMBL727225 0.94 DGKA (0.53) DGKALMNAKDM4EDUSP3MEN1
Propene SCHEMBL11588452 0.93 DGKA (0.54) DGKALMNAKDM4EDUSP3MEN1
SCHEMBL3462028 0.92 DGKA (0.61) DGKALMNAKDM4EDUSP3MEN1
SCHEMBL750550 0.92 DGKA (0.75) DGKALMNAKDM4EDUSP3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 592 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4647070-A2 A PHARMACEUTICAL COMPOSITION FOR REDUCING LOCAL FAT AND USES THEREOF Caliway Biopharmaceuticals Co. Ltd. (TW) 2025-11-12 EP claimed
CN-114681432-B Butylphthalide composition and application thereof 中国科学院上海药物研究所 2024-07-02 CN claimed
EP-3383371-B1 PHARMACEUTICAL FORMULATION AVECHO BIOTECHNOLOGY LTD (AU) 2024-05-01 EP claimed
CN-117899035-A Amisulpride tablet and preparation method thereof 南京正科医药股份有限公司 2024-04-19 CN claimed
CN-117899039-A Compound glycyrrhizin tablet and preparation method thereof 江苏鹏鹞药业有限公司 2024-04-19 CN claimed
CN-117214342-B Method for measuring micelle concentration in injection micelle solution 江苏诺和必拓新药研发有限公司 2024-01-26 CN claimed
CN-117427058-A Pharmaceutical composition containing phenol derivative, preparation method and application thereof 天地恒一制药股份有限公司 2024-01-23 CN claimed
CN-117281886-A Casein hydrolysate bioactive peptide composition and preparation method thereof 深圳翰宇药业股份有限公司 2023-12-26 CN claimed
CN-117214342-A Method for measuring micelle concentration in injection micelle solution 江苏诺和必拓新药研发有限公司 2023-12-12 CN claimed
CN-117136957-A Suspending agent containing spinosad and chlorantraniliprole and preparation method thereof 江苏艾津作物科技集团有限公司 2023-12-01 CN claimed
CN-101647774-B Asarone injection and preparation method thereof UNIV SICHUAN 2011-04-27 CN claimed
CN-101953807-A Mycophenolate mofetil lyophilized powder injection for injection and preparation method thereof SHANXI PUDE PHARMACEUTICAL CO LTD 2011-01-26 CN claimed
US-7718599-B2 Pharmaceutical administration form for peptides, process for its preparation, and use AETERNA ZENTARIS GMBH (DE) 2010-05-18 US claimed
CN-101091890-A Composite type emulsifier, and emulsion prepared by using the emulsifier, and preparation method UNIV SHENYANG PHARMACY (CN) 2007-12-26 CN claimed
CN-1208047-C Self-emulsifying agent for lipophilic compounds PHARMACIA & UPJOHN CO LLC (US) 2005-06-29 CN claimed
US-6531139-B1 Self-emulsifying formulation which provide high concentration and high oral bioavailability for lipophilic, pharmaceutically active agents PHARMACIA & UPJOHN COMPANY 2003-03-11 US claimed
US-6231887-B1 DRUGS OF PYRANONE DERIVATIVES PHARMACIA & UPJOHN COMPANY 2001-05-15 US claimed
EP-1043973-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING MICELLES COMPRISING LIPOPHILIC GLUCOCORTICOSTEROID AND ONLY ONE SURFACTANT AstraZeneca AB (SE) 2000-10-18 EP claimed
WO-1999032089-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING MICELLES COMPRISING LIPOPHILIC GLUCOCORTICOSTEROID AND ONLY ONE SURFACTANT ASTRAZENECA AB (SE) 1999-07-01 WO claimed
US-5047396-A Cyclosporins, monester of hydroxylated fatty acid with ethylene glycol and mono or polyvalent alcohols BIOGAL GYOGYSZERGYAR (HU) 1991-09-10 US claimed